InsidersTradesSigma
Browse the complete record of transactions filed by Henderson Jeffrey William, Director. Director active across 4 companies, notably Halozyme Therapeutics, INC.. In total, 9 filings have been logged. The latest transaction was filed on 16 June 2022 — Attribution. Regulator: SEC (Form 4). All data is free.
9 of 9 declarations
Henderson Jeffrey William is a Director at Halozyme Therapeutics, Inc., FibroGen Inc, and Becton Dickinson & Co. As a board member, he plays a key role in overseeing the activities of these companies and strategic decision-making. His expertise is essential in ensuring good governance and supporting the growth of these organizations.